Shorts could get obliterated
Sentiment: Strong Buy
They haven't proceeded with the phase III though have they? Sounds like that's on the back burner at this point. They said they are focusing on the current phase IIb trial.
More than that considering very low MC, there is so much crappola bios trading at much higher MC's. This is a winner for the patient ones. Of course we need good results and FDA approval. But no less than $30 imho